Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Filings indexed 653 across all filing types
Latest filing 2013-01-31 Share Issue/Capital Cha…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
ÄNDRING AV ANTALET AKTIER OCH RÖSTER I KARO BIO
Share Issue/Capital Change Classification · 98% confidence The document is a short announcement dated January 31, 2013, titled 'ÄNDRING AV ANTALET AKTIER OCH RÖSTER I KARO BIO' (Change in the Number of Shares and Votes in Karo Bio). It explicitly states the total number of shares (495,947,369) and attributes the increase to a rights issue ('nyemission') that was previously announced. This directly concerns a change in the company's capital structure via the issuance of new shares. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it an announcement of a report (RPA) as it contains the core information itself.
2013-01-31 Swedish
CHANGE OF THE NUMBER OF SHARES AND VOTES IN KARO BIO
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document explicitly announces a 'CHANGE OF THE NUMBER OF SHARES AND VOTES IN KARO BIO' due to a completed rights issue. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA), which covers updates on new share issues and capital structure changes. The document is short and is a direct announcement, not a placeholder for a larger report.
2013-01-31 English
Till Karo Bios intressenter: pressmeddelande distribuerat vid felaktig tidpunkt
Report Publication Announcement Classification · 99% confidence The document text is a short communication (559 characters) from Cision apologizing for the premature distribution of a press release from Karo Bio. The content explicitly mentions a press release titled 'ÄNDRINGAV ANTALETAKTIER OCH RÖSTER I KAROBIO' (Change in the number of shares and votes in Karo Bio) that was sent out too early. Since this is an announcement about a distribution error concerning a corporate action (change in shares/votes), and it is very short, it is best classified as a general Regulatory Filing (RNS) or potentially related to a share change (SHA). However, given the focus is on the distribution error and apology rather than the substance of the share change itself, RNS is the most appropriate general regulatory fallback for this type of administrative announcement, especially since the actual filing detailing the share change is not present.
2013-01-30 Swedish
RIGHTS ISSUE IN KARO BIO COMPLETED
Capital/Financing Update Classification · 98% confidence The document is explicitly titled "PRESS RELEASE" and details the completion of a "RIGHTS ISSUE" where new shares were issued, raising capital (SEK 32.6m). This clearly relates to a company fundraising or capital structure change activity. Based on the definitions, the most appropriate category is Capital/Financing Update (CAP). Although it is a press release, its core content is the financing event itself, not just an announcement of a report (RPA) or a general regulatory filing (RNS). The document confirms the subscription details, the amount raised, and the resulting total share count, which are key elements of a capital update.
2012-12-18 English
NYEMISSIONEN I KARO BIO ÄR GENOMFÖRD
Capital/Financing Update Classification · 98% confidence The document is a press release announcing the completion of a new share issue ('Nyemissionen i Karo Bio är genomförd'). It details the number of shares issued, the capital raised (32.6 mkr), and mentions specific directors subscribing to shares. This activity directly relates to changes in the company's capital structure and fundraising efforts. Based on the definitions, this fits best under 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). The document is short and appears to be an official announcement, but the core subject is capital raising, making CAP the most specific fit over the general RNS.
2012-12-18 Swedish
KARO BIO OFFENTLIGGÖR PROSPEKT GÄLLANDE FÖRETRÄDESEMISSIONEN
Report Publication Announcement Classification · 99% confidence The document is a press release titled "KARO BIO OFFENTLIGGÖR PROSPEKT GÄLLANDE FÖRETRÄDESEMISSIONEN" (Karo Bio publishes prospectus regarding the rights issue). It explicitly states that the prospectus has been approved and registered by the Swedish Financial Supervisory Authority (Finansinspektionen) and details how shareholders can receive the prospectus and subscription forms. This announcement concerns a fundraising/capital structure activity (rights issue) and the publication of the associated legal document (prospectus). Since the document is an announcement about a capital action and the associated legal document, the most fitting category is Capital/Financing Update (CAP). Although it mentions a prospectus, the primary focus is the rights issue announcement itself, not the detailed prospectus document, nor is it a general regulatory filing (RNS). It is not a general share issue (SHA) as it specifically relates to a rights issue/fundraising effort.
2012-11-26 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.